September 19, 2023 – September 21, 2023

 

 

Earn up to 8.25 CME/CE
swoosh
swoosh

AGENDA

*All sessions listed in Eastern time. Agenda subject to change. 

SEPTEMBER 19, 2023
7:30 PM - 8:55 PM
Concurrent Sessions

SEPTEMBER 19, 2023
7:30 PM - 8:55 PM Concurrent Sessio

ENHANCE YOUR EXPERIENCE WITH MEDCHALLENGE!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

SEPTEMBER 20, 2023
7:30 PM - 8:55 PM Concurrent Sessions

SEPTEMBER 19, 2023
7:30 PM - 8:55 PM Concurrent Sessions

SEPTEMBER 21, 2023
7:30 PM - 8:50 PM Concurrent Sessions

SEPTEMBER 19, 2023
7:30 PM - 8:55 PM Concurrent Sessions

Callout Info for program

PART I

PART II

LEARNING OBJECTIVES

Upon completion of Session VI, participants will:

    • Increase knowledge of clinically relevant tools to assess cognitive impairment in older adults 
    • Increase competence in the ability to accurately diagnose early stages of Alzheimer's disease
    • Increase knowledge of the mechanism of action of emerging pharmacotherapies for the management of Alzheimer's disease 
    • Increase knowledge of clinical trial data for emerging pharmacotherapies for the management of Alzheimer
    • Increased knowledge regarding the recent trial data on emerging interventional techniques
    • Greater competence related to selection of appropriate patients for emerging interventional techniques

SESSION CHAIR

 

LEARNING OBJECTIVES

Upon completion of Session VII, participants will:

  • Increased knowledge regarding
    • Increase knowledge of clinical data for calcitonin gene-related peptide (CGRP)-targeted therapies studied for the management of migraine
    • Increase knowledge of clinical factors for the identification of patients who may be candidates for a CGRP-targeted therapy for the management of migraine
    • Increase competence in the selection of an appropriate CGRP-targeted therapy for the management of migraine
    • Increase knowledge of factors involved in the identification of patients who are candidates for a non-oral acute migraine therapy
    • Increase competence in the selection of an appropriate non-oral acute therapy for the management of migraine
    • Increase knowledge of clinical data for devices used for the management of migraine 
    • Increase knowledge of factors involved in the identification of patients who may be candidates for a device-based therapy for the management of migraine

SESSION CHAIR

 

LEARNING OBJECTIVES

Upon completion of Session VIII, participants will:

    • Increase knowledge of the pathophysiologic basis of muscular dystrophies
    • Increase knowledge of strategies to reduce the time to diagnosis of muscular dystrophies
    • Increase knowledge of clinical data for new and emerging therapies for the management of muscular dystrophies
    • Increase knowledge of strategies to support patient access of timely care following a diagnosis of spinal muscular atrophy (SMA)
    • Increase knowledge of clinical trial data for therapies used for the management of SMA
    • Increase competence in the development of a comprehensive treatment plan for the management of adults with SMA

SESSION CHAIRS

 

LEARNING OBJECTIVES

Upon completion of Session IX, participants will:

  • Increased knowledge regarding
    • Increase knowledge of factors involved in the successful use of telemedicine to deliver high-quality neurologic care
    • Increase knowledge of the roles and responsibilities of the healthcare team for optimal care via telemedicine 

      Increase knowledge of data indicating disparities in care among patients of diverse racial or ethnic backgrounds

    • Increase knowledge of the roles and responsibilities of the healthcare team in ensuring equitable care for neurology patients

SESSION CHAIR

 

⌃